WallStreetZenWallStreetZen

NASDAQ: TDAC
Translational Development Acquisition Corp Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Translational Development Acquisition earnings were $6.4M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest TDAC earnings report on Dec 31, 2025 announced Q4 2025 earnings of $1.6M, down 3.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TDAC reported annual earnings of $6.4M, with -9,059.7% growth.

TDAC earnings history

Current Revenue
$0.0
Current Earnings
$6.4M
Current Profit Margin
0%

TDAC Return on Equity

Current Company
-101.7%
Current Industry
113.3%
Current Market
28.9%
TDAC's Return on Equity (-101.7%)... subscribe to Premium to read more.
High Return on Equity Performance

TDAC Return on Assets

Current Company
3.6%
Current Industry
1.3%
TDAC is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TDAC announces earnings.

TDAC Return on Capital Employed

Current Company
3.51%
Current Industry
1.4%

TDAC vs Shell Company Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TDAC$6.36M$6.36MN/A$0.29
TWLV$37.03k$37.03kN/A$0.01
ETHM-$13.22M-$13.22MN/A-$0.60
MACI$6.08M$5.54M0.00%$0.26
LATA$1.53M$1.53MN/A$0.11
View Top Shell Company Stocks

Translational Development Acquisition Earnings Reports & History FAQ

What were Translational Development Acquisition's earnings last quarter?

Translational Development Acquisition (NASDAQ: TDAC) reported Q4 2025 earnings per share (EPS) of $0.07, up Infinity% year over year. Total TDAC earnings for the quarter were $1.60 million. In the same quarter last year, Translational Development Acquisition's earnings per share (EPS) was $0.00.

If you're new to stock investing, here's how to buy Translational Development Acquisition stock.

Is Translational Development Acquisition profitable or losing money?

As of the last Translational Development Acquisition earnings report, Translational Development Acquisition is currently profitable. Translational Development Acquisition's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $6.36 million, a 9,059.65% decrease year over year.

What was TDAC's earnings growth in the past year?

As of Translational Development Acquisition's earnings date in Q2 2026, Translational Development Acquisition's earnings has grown year over year. TDAC earnings in the past year totalled $6.36 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.